ACDN-01

N/A

Report date: 2024/09/06 11:26:59

Base Information

Drug NameACDN-01
Drug Alias NameACDN-01
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRetinal-specific phospholipid-transporting ATPase ABCA4 modulators
TargetsRetinal-specific phospholipid-transporting ATPase ABCA4
Therapy Area/IndicationsWet age-related macular degenerationStargardt DiseaseCone-Rod Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAscidian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAscidian Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsWet age-related macular degenerationStargardt DiseaseCone-Rod Dystrophies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A